The goal of this eNewsletter is to keep scientists informed of the latest information regarding grant and award opportunities in Life Sciences. If you think you've received this email in error or do not wish to receive future emails from us, please do so through the e-mail you were sent. Please accept our apology.
The Angelman Syndrome Foundation announces the availability of $300,000 to be awarded in support of research on Angelman syndrome. Angelman syndrome is a neurodevelopmental disorder caused by a deficiency of the ubiquitin protein ligase UBE3A in the brain. Applications related to any area of research involving Angelman syndrome will be considered; highest priority will be given to pilot projects to test new ideas about the pathogenesis of, therapy for, and educational best practices in Angelman syndrome. Researchers from all countries are encouraged to apply. One-year grants awarded for amounts of up to $100,000. More info: www.angelman.org
The Food and Drug Administration For more information regarding the Office of OPD, please visit the following website: http://www.fda.gov/orphan FY 2008, grants deadline February 7, 2007
Applications that help address the inflammatory bowel complications that can cause severe problems in this disorder are particularly welcome. Basic Grant Awards ($400,000) are also offered to support short-term, small-scale pilot or proof of concept research projects that may lead to new avenues of investigation and understanding of CGD. Awards beginning early in 2007 More info: www.cgd.org.uk/research_home.htm Deadline: May 19, 2006
This prestigious new award, sponsored by Microsoft Research, is designed to recognise and reward scientists working in Europe who have made a major contribution to the advancement of science through the use of computational methods. The 2006 award is open to any research scientist who has made a significant contribution at the intersection of the biological sciences and computing. In 2007, the award will focus on computing and the physical sciences. The award will comprise a trophy and a monetary amount of €250,000, of which €7,500 will constitute prize money with the rest earmarked for further research. The award will be presented at a ceremony in October/November 2006. More Info: http://www.royalsoc.ac.uk/page.asp?tip=1&id=4236
The CRF Individual Grants Program was founded on the understanding that effective treatments for acute and chronic spinal cord injury will involve carefully orchestrated multi-disciplinary interventions, each tailored to the individual patient. For this reason, the Individual Grants Program, the largest and most comprehensive of the CRF research initiatives, supports investigator-initiated research on a variety of fronts, including axon growth and guidance, remyelination, cellular replacement, rehabilitation and neuroprotection. More info: http://www.christopherreeve.org
Interested individuals are encouraged to contact the CF Foundation for further information on application procedures and/or to discuss the potential relevance of their work to the objectives of these programs.
Please direct inquiries to: More info: http://www.cff.org/research/cystic_fibrosis_foundation_grants/research_grants/
The signature of the principal investigator is no longer required as a part of a submitted application. Instead, a new compliance requirement is now being implemented where the applicant organization agrees to secure and retain at the organization a written assurance from the principal investigator (PI) prior to submitting an application to the PHS. This change is effective with competing applications submitted for submission/receipt dates May 10, 2006 and thereafter. |
Angelman Syndrome Foundation
The Chronic Granulomatous Disorder Research Trust
The Royal Society and Académie des Sciences Microsoft European Science Award
Christopher Reeve Foundation
Cystic Fibrosis Foundation Grants
NIH Announces Change in Business Process: Replacing principal investigator signature on grant applications, progress reports, and prior approval requests with an institutional compliance requirement.| We would like your feedback Help us to serve you better! Please email us at grantnews@comcast.net Are you receiving a forwarded copy of this eNewsletter? Subscribe Now! By subscribing to this Newsletter you are also agreeing to receive occasional third-party announcements of special offers relevant to your research field. Please place Science_Info@mail.vresp.com and scienceinfo17@comcast.net email addresses in your addresses book to ensure that it won't be filtered out by your email filters. Be sure to visit the Scienceinfo's brand new website at www.newgrantinfo.com © 2006 ScienceInfo |